“Alcidion ..., will now be a leader in the UK health tech market for patient flow and command centre communications, following the acquisition.“
Alcidion acquires UK patient flow software company ExtraMed April 16, 2021
Lisa Baker, Editor
ExtraMed, which provides patient flow software to NHS trusts, has been acquired by smart health tech provider Alcidion Group in a move that will provide an enhanced offering to hospitals and associated primary and social care organisations.
Smart health technology provider Alcidion Group has today announced the strategic acquisition of ExtraMed, a UK company which specialises in providing NHS trusts with software that helps frontline staff make informed decisions based on real-time visibility of patient flow.
Alcidion, which already works with more than 40 hospitals across the UK through its Miya product suite, which includes the electronic observations module Patientrack, will now be a leader in the UK health tech market for patient flow and command centre communications, following the acquisition.
ExtraMed currently has 9 customers in the NHS, including involvement as a partner in a 10-year Digital Control Centre project at Salford Royal NHS Foundation Trust – part of the Northern Care Alliance NHS Group.
In the immediate instance the companies will maintain business as usual, but a combination of shared knowledge across the organisations is expected to quickly lead to enhanced offerings for existing and new customers across the NHS. New opportunities are expected for customers around integration, automation, clinical decision support, resource management, patient observation and clinical communication.
Lynette Ousby, UK general manager for Alcidion, said: “Bringing ExtraMed and its team of experts in patient flow into the Alcidion Group is a fantastic opportunity to further enhance how we work with hospitals across the UK. The combination of our capabilities and our expanding partner network opens up exciting possibilities as we continue to grow our offering to help NHS hospitals and integrated care systems that want to advance digital maturity by complementing and orchestrating their existing systems.
“Existing ExtraMed customers will benefit from the knowledge and experience we have in developing and delivering technological systems that improve patient care, while current Alcidion customers may take advantage of the digital expertise ExtraMed has in patient flow, in ensuring that each patient gets to the right bed at the right time.
Susan Say, managing director of ExtraMed, said: “All of our customers will continue to receive the same high standard of service as our team joins the wider Alcidion family. The Alcidion Group is a perfect fit for ExtraMed, as we join a clinically driven organisation with a strong history grounded in patient safety and digital innovation. We look forward to expanding what we can do for our existing customers and other hospitals in the NHS as well as strengthening our bond with the Northern Care Alliance.”
Under the agreement Alcidion will purchase 100% of the shares in ExtraMed, a wholly-owned subsidiary of bedside communication and entertainment unit provider Hospedia. All staff, customers and assets are included in the acquisition agreement.
Kate Quirke, Managing Director of the Alcidion Group said, “This acquisition significantly strengthens our position in the UK and signifies our commitment to this very important market. We are delighted to welcome the ExtraMed customers and the highly experienced ExtraMed team as we continue to transform the delivery of healthcare with smart technology solutions.
“In combining our customer bases and the established solutions alongside Miya Precision, we are creating a strong competitive advantage and the opportunity for further growth as we look to introduce our Miya product range to these new customers. The combination of our technologies, staff and customers establishes Alcidion as the UK market leader for patient flow and command centre communications.”
ALC Price at posting:
41.0¢ Sentiment: Buy Disclosure: Held
